利用基于MRI估算的Ki-67图引导胶质瘤首次活检:传统影像与先进影像对比
前瞻性临床试验纳入未治疗胶质瘤患者,采集立体定向活检标本,用23项影像参数构建机器学习模型从影像估算Ki-67指数。随机森林模型以4项影像输入预测Ki-67的RMS误差为3.5%(R2=0.75),仅用传统影像时RMS误差为5.4%(R2=0.50)。Ki-67预测图或可用于引导活检、切除和/或放疗。
要点
- 随机森林模型用T2加权、各向异性分数、脑血流量、Ktrans预测Ki-67,RMS误差3.5%(R2=0.75)。
- 仅用传统影像预测的RMS误差为5.4%(R2=0.50),先进影像提高预测准确性。
- Ki-67预测图或可用于引导胶质瘤患者的活检、切除和/或放疗。
核心结论
- 临床影像数据能以临床有用的准确度预测Ki-67,先进影像(扩散、灌注和渗透性)较仅传统影像提高预测准确性。
- 以图形图显示的Ki-67预测或可用于引导胶质瘤患者的活检、切除和/或放疗。
研究设计与样本
- 前瞻性临床试验纳入未治疗胶质瘤患者,手术切除前立即采集立体定向活检标本。
- 对每例活检开发23项影像参数描述并记录Ki-67指数,构建机器学习模型从影像输入估算Ki-67,并进行交叉验证确定估计误差。
主要发现
- 从23例可评估患者采集52份影像引导活检。
- 随机森林算法以4项影像输入(T2加权、各向异性分数、脑血流量、Ktrans)最佳建模Ki-67,预测Ki-67表达水平的RMS误差为3.5%(R2=0.75)。
- 仅使用传统影像时预测结果较不准确,RMS误差为5.4%(R2=0.50)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Undersampling of gliomas at first biopsy is a major clinical problem, as accurate grading determines all subsequent treatment. We submit a technological solution to reduce the problem of undersampling by estimating a marker of tumor proliferation (Ki-67) using MR imaging data as inputs, against a stereotactic histopathology gold standard. METHODS: MR imaging was performed with anatomic, diffusion, permeability, and perfusion sequences, in untreated glioma patients in a prospective clinical trial. Stereotactic biopsies were harvested from each patient immediately prior to surgical resection. For each biopsy, an imaging description (23 parameters) was developed, and the Ki-67 index was recorded. Machine learning models were built to estimate Ki-67 from imaging inputs, and cross validation was undertaken to determine the error in estimates. The best model was used to generate graphical maps of Ki-67 estimates across the whole brain. RESULTS: Fifty-two image-guided biopsies were collected from 23 evaluable patients. The random forest algorithm best modeled Ki-67 with 4 imaging inputs (T2-weighted, fractional anisotropy, cerebral blood flow, Ktrans). It predicted the Ki-67 expression levels with a root mean square (RMS) error of 3.5% (R2 = 0.75). A less accurate predictive result (RMS error 5.4%, R2 = 0.50) was found using conventional imaging only. CONCLUSION: Ki-67 can be predicted to clinically useful accuracies using clinical imaging data. Advanced imaging (diffusion, perfusion, and permeability) improves predictive accuracy over conventional imaging alone. Ki-67 predictions, displayed as graphical maps, could be used to guide biopsy, resection, and/or radiation in the care of glioma patients.
引用
- Gates EDH, Lin JS, Weinberg JS, et al. Guiding the first biopsy in glioma patients using estimated Ki-67 maps derived from MRI: conventional versus advanced imaging. Neuro Oncol. 2019. PMID: 30657997. doi:10.1093/neuonc/noz004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。